Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort

OncoImmunology

Volumn 2, Issue 3, 2013, Pages

  Prada, Nicole ^a,b   Antoni, Guillemette ^c,d   Commo, Frédéric ^a,e   Rusakiewicz, Sylvie ^a   Semeraro, Michaela ^a   Boufassa, Faroudy ^d   Lambotte, Olivier ^c,f,g   Meyer, Laurence ^c,d   Lise, Marie Gougeon ^b   Zitvogel, Laurence ^g  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT PASTEUR   (France)

^c BICÊTRE HOSPITAL   (France)

^d CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^e IGR   (France)

^f INSERM   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

HIV 1; Immunosurveillance; Natural course of infection; NK; NKp30 isoforms

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; ISOPROTEIN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PROTEIN NKP30A; PROTEIN NKP30B; PROTEIN NKP30C; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL EXPANSION; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL SURVIVAL; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS LOAD;

EID: 84886943438     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.23472     Document Type: Article

References (32)

1. Borrow P, Shattock RJ, Vyakarnam A. Innate immunity against HIV: a priority target for HIV prevention research. Retrovirology 2010; 7:84; PMID: 20937128; DOI: 10.1186/1742-4690-7-84.
2. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet 2006; 7:277-300; PMID: 16824023; DOI: 10.1146/annurev.genom.7.080505.115726.
3. Moretta L, Moretta A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004; 23:255-9; PMID: 14685277; DOI: 10.1038/sj.emboj.7600019.
4. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Aricò M, Moretta L, et al. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005; 106:566-71; PMID: 15784725; DOI: 10.1182/blood-2004-10-4035.
5. Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med 2009; 206:1495-503; PMID: 19528259; DOI: 10.1084/jem.20090681.
6. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, Ortolano S, et al. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 2006; 203:2339-50; PMID: 17000867; DOI: 10.1084/jem.20060894.
7. Rutjens E, Mazza S, Biassoni R, Koopman G, Ugolotti E, Fogli M, et al. CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV-1 infection. Eur J Immunol 2010; 40:1440-50; PMID: 20306468; DOI: 10.1002/eji.200940062.
8. Yutkin V, Pode D, Pikarsky E, Mandelboim O. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study. J Urol 2007; 178:2660-4; PMID: 17945285; DOI: 10.1016/j.juro.2007.07.118.
9. De Maria A, Fogli M, Mazza S, Basso M, Picciotto A, Costa P, et al. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol 2007; 37:445-55; PMID: 17273991; DOI: 10.1002/eji.200635989.
10. Chisholm SE, Howard K, Gómez MV, Reyburn HT. Expression of ICP0 is sufficient to trigger natural killer cell recognition of herpes simplex virus-infected cells by natural cytotoxicity receptors. J Infect Dis 2007; 195:1160-8; PMID: 17357052; DOI: 10.1086/512862.
11. Fuller CL, Ruthel G, Warfield KL, Swenson DL, Bosio CM, Aman MJ, et al. NKp30-dependent cytolysis of filovirus-infected human dendritic cells. Cell Microbiol 2007; 9:962-76; PMID: 17381429; DOI: 10.1111/j.1462-5822.2006.00844.x.
12. Mavoungou E, Held J, Mewono L, Kremsner PG. A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells. J Infect Dis 2007; 195:1521-31; PMID: 17436233; DOI: 10.1086/515579.
13. Neville MJ, Campbell RD. A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC. J Immunol 1999; 162:4745-54; PMID: 10202016.
14. Nalabolu SR, Shukla H, Nallur G, Parimoo S, Weissman SM. Genes in a 220-kb region spanning the TNF cluster in human MHC. Genomics 1996; 31:215-22; PMID: 8824804; DOI: 10.1006/geno.1996.0034.
15. Cohen GB, Gandhi RT, Davis DM, Mandelboim O, Chen BK, Strominger JL, et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999; 10:661-71; PMID: 10403641; DOI: 10.1016/S1074-7613(00)80065-5.
16. Cerboni C, Neri F, Casartelli N, Zingoni A, Cosman D, Rossi P, et al. Human immunodeficiency virus 1 Nef protein downmodulates the ligands of the activating receptor NKG2D and inhibits natural killer cell-mediated cytotoxicity. J Gen Virol 2007; 88:242-50; PMID: 17170457; DOI: 10.1099/vir.0.82125-0.
17. Fausther-Bovendo H, Sol-Foulon N, Candotti D, Agut H, Schwartz O, Debré P, et al. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. AIDS 2009; 23:1077-87; PMID: 19424050; DOI: 10.1097/QAD.0b013e32832cb26b.
18. Alter G, Heckerman D, Schneidewind A, Fadda L, Kadie CM, Carlson JM, et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 2011; 476:96-100; PMID: 21814282; DOI: 10.1038/nature10237.
19. Pelak K, Need AC, Fellay J, Shianna KV, Feng S, Urban TJ, et al. Copy number variation of KIR genes influences HIV-1 control. PLoS Biol 2011; 9:e1001208; PMID: 22140359; DOI: 10.1371/journal.pbio.1001208.
20. Thomas R, Low HZ, Kniesch K, Jacobs R, Schmidt RE, Witte T. Nkg2c Deletion Is a Risk Factor of Hiv Infection. AIDS Res Hum Retroviruses 2012; 28:844-51; PMID: 22074011.
21. Tomescu C, Abdulhaqq S, Montaner LJ. Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN). Clin Exp Immunol 2011; 164:158-69; PMID: 21413945; DOI: 10.1111/j.1365-2249.2011.04379.x.
22. Altfeld M, Fadda L, Frleta D, Bhardwaj N. DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol 2011; 11:176-86; PMID: 21350578; DOI: 10.1038/nri2935.
23. Reitano KN, Kottilil S, Gille CM, Zhang X, Yan M, O'Shea MA, et al. Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. AIDS Res Hum Retroviruses 2009; 25:1029-37; PMID: 19795986; DOI: 10.1089/aid.2008.0311.
24. Melki MT, Saïdi H, Dufour A, Olivo-Marin JC, Gougeon ML. Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk-a pivotal role of HMGB1. PLoS Pathog 2010; 6:e1000862; PMID: 20419158; DOI: 10.1371/journal.ppat.1000862.
25. De Maria A, Fogli M, Costa P, Murdaca G, Puppo F, Mavilio D, et al. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 2003; 33:2410-8; PMID: 12938217; DOI: 10.1002/eji.200324141.
26. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, et al. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 2005; 102:2886-91; PMID: 15699323; DOI: 10.1073/pnas.0409872102.
27. Fauci AS, Mavilio D, Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 2005; 5:835-43; PMID: 16239902; DOI: 10.1038/nri1711.
28. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp Hematol 1996; 24:406-15; PMID: 8599969.
29. Delahaye NF, Rusakiewicz S, Martins I, Ménard C, Roux S, Lyonnet L, et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med 2011; 17:700-7; PMID: 21552268; DOI: 10.1038/nm.2366.
30. Mavilio D, Benjamin J, Daucher M, Lombardo G, Kottilil S, Planta MA, et al. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A 2003; 100:15011-6; PMID: 14645713; DOI: 10.1073/pnas.2336091100.
31. Kwon DS, Kaufmann DE. Protective and detrimental roles of IL-10 in HIV pathogenesis. Eur Cytokine Netw 2010; 21:208-14; PMID: 20732847.
32. Faure S, Meyer L, Costagliola D, Vaneensberghe C, Genin E, Autran B, et al. Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science 2000; 287:2274-7; PMID: 10731151; DOI: 10.1126/science.287.5461.2274.